Use of artificial intelligence and machine learning (AI/ML) in drug discovery and development has seen a rapid rise in the past few years, and that progress has been leveraged for the COVID-19 pandemic as well. Two of the leading developers of vaccines against SARS-CoV-2 have used it in their own efforts, and experts and industry insiders are already thinking about how to apply the technology in future pandemics.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?